Stephens Sticks to Their Buy Rating for CareTrust REIT

By Jason Carr

Stephens analyst Dana Hambly reiterated a Buy rating on CareTrust REIT (NASDAQ: CTRE) today and set a price target of $19. The company’s shares closed yesterday at $15.69.

According to, Hambly is a 2-star analyst with an average return of 2.5% and a 50.0% success rate. Hambly covers the Services sector, focusing on stocks such as Encompass Health Corporation, Capital Senior Living, and Team Health Holdings.

CareTrust REIT has an analyst consensus of Moderate Buy, with a price target consensus of $19.

Based on CareTrust REIT’s latest earnings report for the quarter ending September 30, the company posted quarterly revenue of $32.95 million and quarterly net profit of $11.23 million. In comparison, last year the company earned revenue of $28.24 million and had a net profit of $8.33 million.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

CareTrust REIT, Inc. is a real estate investment company, which engages in the ownership, acquisition, and leasing of healthcare-related properties. It operates skilled nursing, assisted living, and independent living facilities. The company was founded on October 29, 2013 and is headquartered in Mission Viejo, CA.